Press Releases by Category Health & Medicine
Peptic Ulcers Pipeline Insight 2025: Emerging Therapies and Clinical Trials Shap …
DelveInsight's "Peptic Ulcers - Pipeline Insight, 2025" examines over 8+ therapies in development for peptic ulcer disease, a condition affecting millions worldwide with peptic ulcer disease symptoms such as abdominal pain, bloating, nausea, and gastrointestinal bleeding. Despite widespread use of existing peptic ulcer disease treatments, including proton pump inhibitors, H2 blockers, and antibiotics for H. pylori eradication, patients with recurrent or complicated peptic ulcers continue to face significant unmet needs,…
Vaso-Occlusive Crisis in Sickle Cell Disease: Emerging Therapies, Clinical Trial …
DelveInsight's "Vaso-Occlusive Crisis (VOC) Associated With Sickle Cell Disease - Pipeline Insight, 2025" provides an in-depth analysis of emerging therapies targeting vaso-occlusive crisis (VOC), a severe and recurring complication of sickle cell disease. Despite current standards of care, including hydroxyurea, patients continue to experience frequent vaso occlusive sickle cell crisis, underscoring the urgent need for effective interventions in sickle cell anemia vaso occlusive crisis treatment.
The VOC pipeline is diversifying with…
Pemphigus Vulgaris Clinical Trials 2025: Emerging Therapies, Key Players, and Tr …
DelveInsight's "Pemphigus Vulgaris - Pipeline Insight, 2025" provides a comprehensive overview of the evolving treatment landscape for pemphigus vulgaris, a rare, chronic, and potentially life-threatening autoimmune blistering disorder. Despite corticosteroids and immunosuppressants being the standard of care, many patients continue to experience relapses, adverse effects, and incomplete disease control, highlighting the urgent need for more effective pemphigus vulgaris treatment options. Understanding bullous pemphigoid vs pemphigus vulgaris is crucial, as both…
IOL Delivery Systems Market to Reach USD 2.9 Billion by 2035, Driven by Technolo …
The global IOL Delivery Systems Market is poised for steady growth, with an estimated value of USD 1.3 billion in 2025, expected to reach USD 2.9 billion by 2035. This growth reflects a compound annual growth rate of 8.5%, underpinned by the rising prevalence of cataract cases and the growing adoption of advanced intraocular lens (IOL) implantation techniques. Modern delivery systems are reshaping cataract surgery by providing surgeons with safer,…
Foot Suction Unit Market to Reach USD 957.0 million by 2035 with Innovations fro …
The Foot Suction Unit Market is poised for significant growth, with market value expected to rise from USD 482.0 million in 2025 to USD 957.0 million by 2035, reflecting a compound annual growth rate (CAGR) of 7.1% over the next decade. This surge is driven by the increasing adoption of portable, efficient, and easy-to-operate surgical suction solutions in healthcare facilities worldwide.
Healthcare providers, particularly hospitals and clinics, are seeking compact units…
Gingival Retraction Kits Market Set to Reach USD 288.3 Million by 2035, Driven b …
The Gingival Retraction Kits Market is witnessing consistent growth, fueled by the increasing emphasis on precision in dental procedures and the widespread adoption of advanced dental practices. Valued at USD 177.8 million in 2025, the market is projected to reach USD 288.3 million by 2035, registering a CAGR of 5.0% over the forecast period.
This growth is supported by the rising demand for minimally invasive dental procedures, which ensure accurate impressions…
Provoked Vestibulodynia Treatment Market to Reach USD 312.6 million by 2035, Dri …
The global Provoked Vestibulodynia Treatment Market is witnessing a significant surge, driven by rising awareness of women's health issues and innovations in therapeutic approaches. Estimated at USD 138.2 million in 2025, the market is projected to reach USD 312.6 million by 2035, reflecting a steady compound annual growth rate (CAGR) of 8.5%. With increasing prevalence of vulvar pain disorders and a focus on personalized care, this market is poised to…
Non-Invasive Glucose Monitoring Market to Reach USD 2,447.99 million by 2032, Gr …
Market Outlook
The Non-Invasive Glucose Monitoring Market has emerged as a critical segment in the healthcare industry, particularly for diabetes management. As of 2018, the market was valued at USD 219.96 million and grew significantly to USD 462.55 million by 2024. With the projected Compound Annual Growth Rate (CAGR) of 21.60%, it is anticipated to reach USD 2,447.99 million by 2032. This rapid expansion reflects a rising global need for painless,…
Pressure Monitoring Extension Tubing Sets Market to Reach USD 299.9 million by 2 …
The Pressure Monitoring Extension Tubing Sets Market is witnessing steady growth, driven by the increasing need for precision patient monitoring across hospitals, clinics, and surgical centers worldwide. Valued at USD 159.8 million in 2025, the market is projected to reach USD 299.9 million by 2035, reflecting a compound annual growth rate (CAGR) of 6.5%.
The expanding healthcare infrastructure, rising prevalence of cardiovascular and chronic conditions, and growing emphasis on patient safety…
Parkinson's Disease Psychosis (PDP) Market reaching approximately USD 3.7 billio …
Parkinson's disease (PD) is a chronic neurodegenerative disorder marked by tremors, rigidity, and movement difficulties. Beyond motor symptoms, many patients also develop Parkinson's disease psychosis (PDP), a non-motor complication characterized by hallucinations and delusions. PDP affects nearly half of advanced PD patients, contributing significantly to morbidity, caregiver burden, and long-term care requirements.
Historically, PDP management has been challenging because many antipsychotics worsen motor symptoms by interfering with dopamine pathways. However, with…
Parkinson's Disease Levodopa-Induced Dyskinesia (LID) Market New Product Develop …
Introduction
Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting movement, characterized by tremors, stiffness, and impaired coordination. Levodopa remains the gold standard for managing motor symptoms, but long-term use often results in levodopa-induced dyskinesia (LID) - a debilitating complication involving involuntary, erratic movements.
As patients live longer due to improved disease management, the incidence of LID continues to rise. The burden of dyskinesia not only reduces quality of life but also…
Non-Invasive Glucose Monitoring Market to Reach USD 2,447.99 million by 2032, Gr …
Market Outlook
The Non-Invasive Glucose Monitoring Market has emerged as a critical segment in the healthcare industry, particularly for diabetes management. As of 2018, the market was valued at USD 219.96 million and grew significantly to USD 462.55 million by 2024. With the projected Compound Annual Growth Rate (CAGR) of 21.60%, it is anticipated to reach USD 2,447.99 million by 2032. This rapid expansion reflects a rising global need for painless,…
Peripheral Nerve Injuries Market reaching approximately USD 4.9 billion by 2034
Peripheral nerve injuries (PNIs) occur when nerves outside the brain and spinal cord are damaged, often leading to loss of motor function, sensory deficits, or chronic neuropathic pain. These injuries are commonly caused by trauma, surgery, repetitive stress, or medical conditions such as diabetes. Depending on severity, PNIs may involve partial or complete disruption of nerve fibers, significantly affecting patient quality of life.
The burden of PNIs is rising globally due…
Post-Traumatic Stress Disorder (PTSD) Market reaching approximately USD 13.4 bil …
Post-traumatic stress disorder (PTSD) is a psychiatric condition that develops after exposure to traumatic events such as combat, natural disasters, serious accidents, or violence. It manifests through symptoms like flashbacks, nightmares, heightened anxiety, and emotional numbness, often impairing daily functioning and quality of life. While once underdiagnosed and stigmatized, PTSD is increasingly recognized as a major public health concern worldwide.
The growing prevalence of PTSD among military veterans, first responders, survivors…
Immunofluorescence Assay Market Size 2025 Emerging Demands, Share, Trends, Futur …
Coherent Market Insights has released a report titled "Immunofluorescence Assay Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032", which includes market percentage records and a thorough enterprise analysis. This report looks at the market's competition, geographic distribution, and growth potential. This comprehensive report encompasses industry performance, critical success factors, risk assessment, manufacturing prerequisites, project expenses, economic analysis, anticipated return on investment (ROI), and profit margins.
➤ Get Sample Copy…
Neuromyelitis Optica Market Detailed Industry Report Analysis 2025-2034
Introduction
Neuromyelitis optica (NMO), also known as Devic's disease, is a rare autoimmune disorder of the central nervous system characterized by severe inflammation of the optic nerves and spinal cord. Patients often experience vision loss, paralysis, sensory impairment, and bladder dysfunction. Once considered a variant of multiple sclerosis (MS), NMO is now recognized as a distinct condition, thanks to advancements in diagnostics such as aquaporin-4 (AQP4) antibody testing.
Though rare, NMO can…
Progressive Supranuclear Palsy (PSP) Market reaching approximately USD 2.2 billi …
Global Progressive Supranuclear Palsy (PSP) Market Outlook 2024-2034
Introduction
Progressive supranuclear palsy (PSP) is a rare neurodegenerative disorder characterized by problems with balance, movement, vision, speech, and cognition. Often misdiagnosed as Parkinson's disease due to overlapping symptoms, PSP is caused by the accumulation of abnormal tau protein in the brain. Unlike Parkinson's, PSP responds poorly to conventional dopaminergic therapies, making treatment a significant clinical challenge.
Growing awareness of rare neurodegenerative disorders, increased investment…
Multiple Sclerosis Market Emerging Trends and Growth Prospects 2034
Introduction
Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system, damaging the myelin sheath and disrupting communication between the brain and body. Characterized by symptoms such as fatigue, vision problems, muscle weakness, and impaired coordination, MS can lead to long-term disability if untreated.
Globally, MS affects nearly 2.8 million people, with incidence rising due to better diagnostic methods, greater awareness, and lifestyle-related risk factors. While MS currently…
Mechanical Thrombectomy Devices Market Size, Demand, Share, Analysis with Focus …
An off-the-shelf report on Mechanical Thrombectomy Devices Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as type/components/ application/industry verticals/ end-users are analyzed with robust research methodology which includes three step process starting with extensive secondary research to gather data from company profiles, global/regional associations, trade…
Spinocerebellar Ataxias (SCA) Market reaching approximately USD 2.6 billion by 2 …
Spinocerebellar ataxias (SCAs) are a group of rare, inherited neurodegenerative disorders characterized by progressive problems with movement, balance, and coordination. Caused by genetic mutations that affect the cerebellum and sometimes other parts of the nervous system, SCAs are classified into multiple subtypes (such as SCA1, SCA2, SCA3, and others), each with distinct genetic and clinical features.
Patients often experience gait instability, slurred speech, vision problems, and difficulty with fine motor skills,…
Leigh Syndrome Market 2025-2034 Business Outlook, Critical Insight and Growth
Introduction
Leigh syndrome, also known as subacute necrotizing encephalomyelopathy, is a rare, progressive neurometabolic disorder that primarily affects infants and young children. Characterized by degeneration of the central nervous system, Leigh syndrome is linked to defects in mitochondrial energy production. The condition is typically associated with mutations in mitochondrial DNA (mtDNA) or nuclear DNA (nDNA), impacting enzymes essential for oxidative phosphorylation.
Symptoms such as developmental delays, muscular weakness, respiratory complications, and neurological…
Atypical Teratoid Rhabdoid Tumors (ATRT) Market reaching approximately USD 1.7 b …
Atypical Teratoid Rhabdoid Tumor (ATRT) is a rare and aggressive brain tumor primarily affecting children, although it can occasionally occur in adults. ATRT is characterized by the rapid growth of undifferentiated cells, typically located in the central nervous system, including the brain and spinal cord. Due to its rarity, the diagnosis and management of ATRT remain challenging. While treatment often includes a combination of surgery, radiation, and chemotherapy, outcomes for…
Child Rehabilitation Market is Poised to Growth USD 103.14 Billion by 2034 with …
The healthcare sector is placing growing emphasis on pediatric rehabilitation, as awareness of developmental disorders, neurological conditions, and physical disabilities in children continues to rise. The Child Rehabilitation Market is emerging as a critical segment within the broader healthcare industry, offering specialized therapies and technologies designed to improve the quality of life for children. With advancements in medical science, increasing healthcare investments, and supportive government policies, the market is projected…
Hypothalamic Obesity Market Set to Witness Significant Growth by 2025-2034
Introduction
Hypothalamic obesity (HO) is a rare and complex disorder caused by damage to the hypothalamus - the brain region responsible for regulating appetite, metabolism, and energy balance. It often occurs as a consequence of brain tumors, neurosurgery, traumatic brain injury, or genetic syndromes such as Prader-Willi. Unlike common obesity, hypothalamic obesity is resistant to traditional lifestyle interventions like diet and exercise, making it one of the most challenging forms of…
Chronic Progressive Multiple Sclerosis (CPMS) Market to Reach USD 6.8 Billion by …
The global chronic progressive multiple sclerosis (CPMS) market is experiencing strong growth due to rising prevalence, advancements in disease-modifying therapies (DMTs), and increasing investments in progressive MS research. Chronic Progressive MS, marked by steady neurological deterioration without remission, remains one of the most challenging forms of the disease to treat.
Despite a historically limited number of therapies targeting disease progression, innovative treatments are emerging. These therapies, along with a growing understanding…
Fibromyalgia Market to Set Phenomenal Growth From 2025 to 2034
Introduction
Fibromyalgia is a chronic disorder characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, memory problems, and mood issues. Despite being a non-life-threatening condition, fibromyalgia profoundly impacts quality of life and work productivity, making it a major public health concern. Affecting predominantly women, fibromyalgia often coexists with conditions like irritable bowel syndrome, migraines, and depression, complicating treatment pathways.
Over the years, growing awareness of fibromyalgia and its recognition as a legitimate medical…
Clinically Isolated Syndrome (CIS) Market reaching approximately USD 2.5 billion …
Clinically Isolated Syndrome (CIS) is a neurological condition that typically serves as the first episode of multiple sclerosis (MS), characterized by a single episode of neurological symptoms caused by inflammation or demyelination of the central nervous system. It is considered a precursor to MS, with many individuals who experience CIS eventually progressing to a diagnosis of relapsing-remitting MS (RRMS).
CIS often presents with symptoms like vision impairment, muscle weakness, and coordination…
Diabetic Peripheral Neuropathy (DPN) Market Emerging Trends and Growth Prospects …
Introduction
Diabetic peripheral neuropathy (DPN) is one of the most common and serious complications of diabetes mellitus, affecting millions of people globally. It occurs when prolonged high blood sugar levels cause nerve damage, particularly in the hands, feet, and legs. Patients with DPN often experience pain, tingling, numbness, and balance issues, which can lead to foot ulcers, infections, and even amputations if untreated.
With diabetes prevalence rising at alarming rates, especially in…
Dementia Market Projected to Reach USD 30.2 Billion by 2034
Dementia is a broad category of cognitive impairments, including memory loss, language difficulties, and poor judgment, often leading to a severe decline in daily functioning. Alzheimer's disease is the most common cause of dementia, but other forms, such as vascular dementia, Lewy body dementia, and frontotemporal dementia, also contribute to the global burden. As the global population ages, the prevalence of dementia is rising, with the number of people affected…
Cognitive Impairment Associated with Schizophrenia (CIAS) Market Detailed Indust …
Introduction
Schizophrenia is a chronic psychiatric disorder affecting approximately 1% of the global population, often characterized by hallucinations, delusions, and social withdrawal. However, beyond these hallmark symptoms, cognitive impairment associated with schizophrenia (CIAS) remains one of the most debilitating aspects of the disease. CIAS manifests as deficits in memory, attention, problem-solving, and executive function, severely limiting patients' ability to live independently, pursue employment, and maintain social relationships.
While traditional antipsychotics effectively manage…
Vital Sign Monitoring Devices Market to Reach USD 13,654.23 million by 2032, Gro …
Market Outlook
The Vital Sign Monitoring Devices market has been experiencing remarkable growth over the past few years, driven by the increasing demand for continuous patient monitoring and advancements in medical technology. The market size was valued at USD 5,263.27 million in 2018 and expanded to USD 7,840.22 million in 2024. It is projected to reach USD 13,654.23 million by 2032, exhibiting a compound annual growth rate (CAGR) of 7.23% during…
Parkinson's Disease-Related Dementia (PDD) Market to Reach USD 7.9 Billion by 20 …
Parkinson's Disease-Related Dementia (PDD) is a progressive neurocognitive disorder that develops in patients with long-standing Parkinson's disease (PD). It is characterized by cognitive decline, memory impairment, visual hallucinations, fluctuating attention, and executive dysfunction, in addition to the motor symptoms of PD.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71917
Up to 75% of PD patients eventually develop dementia, making PDD a significant public health challenge. The market is shaped by…
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Growth, Trends, …
Introduction
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare autoimmune disorder characterized by progressive weakness and impaired sensory function in the arms and legs due to damage to the myelin sheath surrounding peripheral nerves. Though uncommon, CIDP significantly affects patient quality of life and requires long-term management, often involving immunotherapy, corticosteroids, and plasma exchange.
Over the past decade, improved diagnostic capabilities, greater awareness of rare neurological diseases, and advancements in immunoglobulin therapies…
Peripheral Neuropathic Pain (PNP) Market to Reach USD 13.9 Billion by 2034
Peripheral neuropathic pain (PNP) is a chronic pain condition caused by nerve damage or dysfunction in the peripheral nervous system, often linked to diabetes, shingles (postherpetic neuralgia), chemotherapy-induced neuropathy, HIV, and traumatic nerve injury. Symptoms include burning pain, tingling, numbness, and hypersensitivity, significantly reducing patient quality of life.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71919
PNP is difficult to treat, as many patients fail to respond to first-line therapies.…
Binge Eating Disorders Market 2025-2034 Business Outlook, Critical Insight and G …
Introduction
Binge eating disorder (BED) is the most common eating disorder worldwide, characterized by recurrent episodes of excessive food consumption without compensatory behaviors such as purging. Unlike occasional overeating, BED is a recognized psychiatric condition that can lead to obesity, diabetes, cardiovascular disease, depression, and diminished quality of life. It is estimated that millions of individuals globally suffer from this disorder, but only a fraction seek professional treatment due to stigma,…
The Next-Gen Beauty Global Cosmeceuticals market is set to surpass USD 113.80 bi …
The cosmeceuticals industry global has undergone significant transformation in the last ten years, largely due to growing awareness among consumers about skin health, increasing disposable incomes, and the desire for multifunctional items that merge cosmetic features with therapeutic advantages. The aim and scope of the cosmeceuticals sector focus on offering products that not only improve looks but also provide biologically active elements addressing various skin issues such as aging, hyperpigmentation,…
Progressive Multifocal Leukoencephalopathy (PML) Market to Reach USD 370 Million …
Progressive Multifocal Leukoencephalopathy (PML) is a rare, often fatal demyelinating disease of the central nervous system caused by reactivation of the John Cunningham virus (JCV), typically in immunocompromised individuals. PML occurs most frequently in patients with HIV/AIDS, hematologic malignancies, organ transplant recipients, and those receiving immunosuppressive biologics (e.g., natalizumab, rituximab).
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71921
The disease is characterized by rapid neurological decline, motor weakness, vision impairment,…
Insomnia Patient Pool Analysis Market to Set Phenomenal Growth From 2025 to 2034
Introduction
Insomnia is one of the most widespread sleep disorders, affecting individuals of all ages worldwide. Characterized by difficulty falling asleep, staying asleep, or achieving restorative sleep, insomnia significantly impacts quality of life and contributes to a variety of comorbidities, including cardiovascular disease, obesity, depression, and anxiety. The modern lifestyle - marked by increased stress levels, digital device use, and irregular sleep schedules - has further contributed to rising cases.
Patient pool…
Parkinson's Disease Market to Reach USD 12.5 Billion by 2034
Parkinson's disease (PD) is a chronic, progressive neurodegenerative disorder characterized by motor symptoms such as tremors, rigidity, bradykinesia, and postural instability, alongside non-motor symptoms including depression, cognitive impairment, and sleep disturbances. The condition results from the progressive loss of dopamine-producing neurons in the substantia nigra, leading to impaired motor control.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71915
Globally, PD is the second most common neurodegenerative disorder after Alzheimer's disease,…
Psychosis in Parkinson's and Alzheimer's Disease Market to Reach USD 6.5 Billion …
Psychosis is a severe non-motor complication associated with Parkinson's disease (PD) and Alzheimer's disease (AD). It is characterized by visual hallucinations, delusions, agitation, and paranoia, which worsen disease progression and caregiver burden. Psychosis develops in up to 60% of Parkinson's patients and nearly 40% of Alzheimer's patients, making it a critical challenge in neurodegenerative care.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71923
Current treatment options are limited, as standard…
Acute Social Anxiety Disorder Market Insights and Future Outlook
Introduction
Social anxiety disorder (SAD), also known as social phobia, is one of the most common anxiety disorders, characterized by an intense fear of being judged, embarrassed, or negatively evaluated in social situations. Acute social anxiety disorder significantly impacts quality of life, leading to avoidance of work, education, and interpersonal relationships. Globally, the condition affects millions, making it a major public health issue with growing economic and social implications.
Over the past…
Brain-Computer Interface (BCI) ASIC Market to Reach USD 630.94 million by 2032, …
Market Outlook
The Global Brain-Computer Interface (BCI) ASIC Market size was valued at USD 75.27 million in 2018 and reached USD 187.23 million in 2024. It is anticipated to grow to USD 630.94 million by 2032, registering a robust Compound Annual Growth Rate (CAGR) of 16.40% during the forecast period. The market is witnessing significant attention due to its potential to redefine human-machine interaction, particularly in healthcare, consumer electronics, and research…
Obsessive-Compulsive Disorder (OCD) Market to Reach USD 12.8 Billion by 2034
Obsessive-Compulsive Disorder (OCD) is a chronic psychiatric disorder characterized by intrusive, distressing thoughts (obsessions) and repetitive behaviors or rituals (compulsions). It significantly impairs quality of life, social functioning, and productivity. While commonly misrepresented as a behavioral quirk, OCD is a serious condition requiring structured clinical care.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71913
OCD affects people of all ages and has a lifetime prevalence of 2-3% globally. Current management…
Acute Ischemic Stroke Market to Set Phenomenal Growth From 2025 to 2034
Introduction
Acute ischemic stroke (AIS) is one of the most serious medical emergencies worldwide, caused by a sudden blockage in a cerebral artery, restricting blood flow to the brain. It is the most common type of stroke, accounting for nearly 85% of all cases. Prompt diagnosis and treatment are critical, as the window for effective interventions like thrombolysis and mechanical thrombectomy is extremely narrow.
With rising incidence rates due to aging populations,…
Multiple System Atrophy (MSA) Market to Double, Reaching USD 420 Million by 2034
Multiple System Atrophy (MSA) is a rare, progressive neurodegenerative disorder characterized by a combination of Parkinsonism, cerebellar ataxia, and autonomic dysfunction. Often misdiagnosed as Parkinson's disease, MSA progresses more rapidly and has limited treatment options. The exact cause remains unknown, but abnormal accumulation of alpha-synuclein in glial cells plays a central role.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71911
Patients typically experience rigidity, tremors, impaired coordination, orthostatic hypotension, urinary…
Candidiasis Market New Product Development & Latest Trends
Introduction
Candidiasis, a fungal infection caused by Candida species, represents a major healthcare challenge worldwide. While Candida albicans is the most common pathogen, emerging strains such as Candida auris are raising global concerns due to their high resistance to antifungal drugs. Candidiasis can affect the mouth (oral thrush), genital areas, bloodstream, and internal organs, with systemic infections often proving life-threatening, especially in immunocompromised patients.
The growing prevalence of hospital-acquired infections (HAIs), rising…
Lewy Body Dementia Market to Reach USD 9.4 Billion by 2034
Lewy Body Dementia (LBD) is the second most common form of progressive dementia after Alzheimer's disease, accounting for 10-15% of dementia cases. It is caused by the abnormal accumulation of alpha-synuclein protein (Lewy bodies) in the brain, leading to cognitive decline, visual hallucinations, fluctuating alertness, REM sleep behavior disorder, and Parkinsonism symptoms.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71909
With aging populations and rising awareness, the LBD market is…
Bacterial Skin Diseases Market Emerging Trends and Growth Prospects 2034
Introduction
Bacterial skin diseases remain among the most common dermatological concerns worldwide, impacting millions of people each year across all age groups. Conditions such as cellulitis, impetigo, folliculitis, and erysipelas often arise from pathogens like Staphylococcus aureus and Streptococcus pyogenes. These infections can range from mild, self-limiting cases to severe conditions requiring hospitalization.
With increasing awareness of skin health, rising global pollution, and changes in lifestyle patterns, the prevalence of bacterial skin…
The India Ayurvedic Products Market is Projected to Hit USD 5.67 Billion by 2035 …
India, the birthplace of Ayurveda, is witnessing an unprecedented surge in demand for natural and holistic healthcare solutions. The India Ayurvedic Products Market is rapidly evolving, driven by increasing consumer preference for herbal remedies, government initiatives to promote Ayurveda, and rising global interest in traditional medicine. With centuries-old practices blending seamlessly with modern science, the market is poised to achieve remarkable growth in the coming years.
As per MRFR analysis, the…
Lambert-Eaton Myasthenic Syndrome (LEMS) Market to Reach USD 280 Million by 2034
Lambert-Eaton Myasthenic Syndrome (LEMS) is a rare autoimmune neuromuscular disorder characterized by muscle weakness of the limbs, fatigue, and autonomic dysfunction. It occurs when antibodies target voltage-gated calcium channels (VGCCs) at the neuromuscular junction, impairing acetylcholine release.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71907
Approximately 50-60% of LEMS cases are paraneoplastic, most often associated with small-cell lung cancer (SCLC). The remainder are autoimmune and non-cancer related. LEMS remains underdiagnosed…
Go To Page 11280 11279 11278 11277 11276 11275 11274 11273 11272 11271 9910 9909 9908 9907 9906 9905 9904 9903 9902 9901
